GB1221006A - Salicylanilides - Google Patents

Salicylanilides

Info

Publication number
GB1221006A
GB1221006A GB5465868A GB5465868A GB1221006A GB 1221006 A GB1221006 A GB 1221006A GB 5465868 A GB5465868 A GB 5465868A GB 5465868 A GB5465868 A GB 5465868A GB 1221006 A GB1221006 A GB 1221006A
Authority
GB
United Kingdom
Prior art keywords
chlorophenoxy
haloalkyl
nov
nitro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5465868A
Other languages
English (en)
Inventor
Victor Joseph Grenda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1221006A publication Critical patent/GB1221006A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB5465868A 1967-11-22 1968-11-18 Salicylanilides Expired GB1221006A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68496667A 1967-11-22 1967-11-22

Publications (1)

Publication Number Publication Date
GB1221006A true GB1221006A (en) 1971-02-03

Family

ID=24750244

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5465868A Expired GB1221006A (en) 1967-11-22 1968-11-18 Salicylanilides

Country Status (4)

Country Link
DE (1) DE1808679A1 (cg-RX-API-DMAC10.html)
ES (1) ES360380A1 (cg-RX-API-DMAC10.html)
GB (1) GB1221006A (cg-RX-API-DMAC10.html)
NL (1) NL6815872A (cg-RX-API-DMAC10.html)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014152536A2 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
US9777006B2 (en) 2013-03-14 2017-10-03 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US9856249B2 (en) 2013-03-14 2018-01-02 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US10350197B2 (en) 2013-03-12 2019-07-16 Celtaxsys, Inc. Methods of inhibiting leukotriene A4 hydrolase
US10898484B2 (en) 2018-05-31 2021-01-26 Celltaxis, Llc Method of reducing pulmonary exacerbations in respiratory disease patients
US12173009B2 (en) 2005-12-29 2024-12-24 Celltaxis, Llc Diamine derivatives as inhibitors of leukotriene A4 hydrolase

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12173009B2 (en) 2005-12-29 2024-12-24 Celltaxis, Llc Diamine derivatives as inhibitors of leukotriene A4 hydrolase
US10350197B2 (en) 2013-03-12 2019-07-16 Celtaxsys, Inc. Methods of inhibiting leukotriene A4 hydrolase
US10898471B2 (en) 2013-03-12 2021-01-26 Celltaxis, Llc Methods of inhibiting leukotriene A4 hydrolase
WO2014152536A2 (en) 2013-03-14 2014-09-25 Celtaxsys, Inc. Inhibitors of leukotriene a4 hydrolase
JP2016516043A (ja) * 2013-03-14 2016-06-02 セルタクシス,インコーポレイテッド ロイコトリエンa4加水分解酵素の阻害剤
EP2968265A4 (en) * 2013-03-14 2016-12-28 Celtaxsys Inc INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
US9777006B2 (en) 2013-03-14 2017-10-03 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US9822106B2 (en) 2013-03-14 2017-11-21 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US9856249B2 (en) 2013-03-14 2018-01-02 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
AU2014239585B2 (en) * 2013-03-14 2019-04-04 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US10501455B2 (en) 2013-03-14 2019-12-10 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
US10898484B2 (en) 2018-05-31 2021-01-26 Celltaxis, Llc Method of reducing pulmonary exacerbations in respiratory disease patients

Also Published As

Publication number Publication date
DE1808679A1 (de) 1969-06-12
ES360380A1 (es) 1970-07-01
NL6815872A (cg-RX-API-DMAC10.html) 1969-05-27

Similar Documents

Publication Publication Date Title
GB1132082A (en) The manufacture of pyrimidine derivatives
IE41102B1 (en) Haloacetanilides as fungicidally active substances
IE38351L (en) Substituted dimethyl anilines; microbiocides
ES360380A1 (es) Un procedimiento para la preparacion de salicilanilidas.
GB1188956A (en) N-Substituted Aromatic Amidines and process for obtaining same
GB1515060A (en) 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters
ITMI942483A1 (it) Composizioni farmaceutiche a rilascio controllato osmotico e per diffusione del farmaco e procedimento per la loro preparazione
IE33371B1 (en) Protozoacidally-active substituted guanidines
IE33111L (en) Spiro-imidazoline-phthalan derivatives
GB1221257A (en) Salicylanilides and thiosalicylanilides
IE33230B1 (en) Anti-haemorrhoidally active preparations for local or rectal administration
GB1476360A (en) Herbicidal compositions
GB1054906A (cg-RX-API-DMAC10.html)
IE33581L (en) Compositions comprising l-dopa
GB1223032A (en) Benzodiazepine derivatives
FR1379M (fr) Un nouveau médicament, l'acide n-(2,3-diméthylphényl)-anthranilique.
IE32943B1 (en) Improvements in or relating to benzylideneamino guanidine derivatives
GB1306933A (en) Insothiosemicarbazones and their preparation
GB1355304A (en) Insecticides
GB1053696A (cg-RX-API-DMAC10.html)
GB1321087A (en) Phosphoric acid esters their preparation and use as pesticides
GB975704A (en) New hydantoin derivative
GB1299228A (en) Codeine and procaine 1-phenyl-2,3-dimethyl-5-pyrazolone-(n-methyl)-4-aminomethanesulphonate
GB1130469A (en) Pre-emergent herbicides and substituted triazenes
ES368815A1 (es) Procedimiento para laobtencion de derivados de la urea.